Skip to main content
SpringerLink
Log in

Cutaneous Vasculitis

  • Chapter
Therapy of Skin Diseases

  • 1461 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Coombs RRA (1992) The Jack Pepys Lecture. The hyper-sensitivity reactions—some personal reflections. Clin Exp Allergy 22:673–680

    Article  PubMed  CAS  Google Scholar 

  2. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL (1998) Cutaneous small-vessel vasculitis. J Am Acad Dermatol 39:667–687

    Article  PubMed  CAS  Google Scholar 

  3. Csernok E, Gross WL (2000) Primary vasculitides and vas-culitis confined to skin: clinical features and new pathogenic aspects. Arch Dermatol Res 292(9):427–436

    Article  PubMed  CAS  Google Scholar 

  4. Sunderkotter C, Seeliger S, Schonlau F, Roth J, Hallmann R, Luger TA, Sorg C, Kolde G (2001) Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol 10(6):391–404

    Article  PubMed  CAS  Google Scholar 

  5. Kanazawa N, Furukawa F (2007) Autoinflammatory syndromes with a dermatological perspective. J Dermatol 34(9):601–618

    Article  PubMed  CAS  Google Scholar 

  6. Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A (2006) Autoinflammatory syndromes. Clin Exp Rheumatol 24(1 suppl 40):S79–S85

    PubMed  CAS  Google Scholar 

  7. Carlson JA, Ng BT, Chen KR (2005) Cutaneous vasculitis update: Diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 27(6):504–528

    Article  PubMed  Google Scholar 

  8. Saleh A, Stone JH (2005) Classification and diagnostic criteria in systemic vasculitis. Best Pract Res Clin Rheumatol 19(2):209–221

    Article  PubMed  Google Scholar 

  9. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65(7):936–941

    Article  PubMed  CAS  Google Scholar 

  10. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192

    Article  CAS  Google Scholar 

  11. Narula N, Gupta S, Narula J (2005) The primary vasculiti-des: a clinicopathologic correlation. Am J Clin Pathol 124 Suppl:S84–S95

    PubMed  Google Scholar 

  12. Martinez–Taboada VM, Blanco R, Garcia-Fuentes M (1997) Clinical features and outcome of 95 patients with hypersen-sitivity vasculitis. Am J Med 102:186–191

    Article  PubMed  Google Scholar 

  13. Sais G, Vidaller A, Jucgla Servitje O, Condom E, Peyri J (1998) Prognostic factors in leukocyoclastic vasculitis: a clinicopathologic study of 160 Patients. Arch Dermatol 134:309–315

    Article  PubMed  CAS  Google Scholar 

  14. Litt JZ (2004) Drug eruption reference manual, 10th edn. Taylor &Francis, London

    Google Scholar 

  15. Sunderkotter C, Bonsmann G, Sindrilaru A, Luger T (2005) Management of leukocytoclastic vasculitis. J Dermatolog Treat 16(4):193–206

    Article  PubMed  CAS  Google Scholar 

  16. Balbir-Gurman A, Nahir AM, Braun-Moscovici Y (2007) Intravenous immunoglobulins in polyarteritis nodosa restricted to the limbs: case reports and review of the literature. Clin Exp Rheumatol 25(1 Suppl 44):S28–S30

    PubMed  CAS  Google Scholar 

  17. Darabi K, Abdel-Wahab O, Dzik WH (2006) Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 46(5):741–753

    Article  PubMed  CAS  Google Scholar 

  18. Aries PM, Hellmich B, Gross WL (2005) Intravenous immu-noglobulin therapy in vasculitis: speculation or evidence? Clin Rev Allergy Immunol 29(3):237–245

    Article  PubMed  CAS  Google Scholar 

  19. Jolles S, Sewell WA, Misbah SA (2005) Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 142(1):1–11

    Article  PubMed  CAS  Google Scholar 

  20. Rech J, Fuchs F, Kallert S, Hueber AJ, Requadt C, Manger B, Kalden JR, Amann K, Strauss R, Schulze-Koops H (2007) Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schonlein purpura with disseminated organ involvement. Clin Rheumatol 26(1):112–114

    Article  PubMed  CAS  Google Scholar 

  21. Guillevin L, Pagnoux C (2003) Indications of plasma exchanges for systemic vasculitides. Ther Apher Dial 7(2):155–160

    Article  PubMed  Google Scholar 

  22. von Kobyletzki G, Stucker M, Hoffmann K, Pohlau D, Hoffmann V, Altmeyer P (1998) Severe therapy-resistant necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of the vasculitis with extracorpo-real immunoadsorption. Br J Dermatol 138(5):926–927

    Article  Google Scholar 

  23. Schneider M, Gaubitz M, Perniok A (1997) Immunoadsorption in systemic connective tissue diseases and primary vasculi-tis. Ther Apher 1(2):117–120

    Article  PubMed  CAS  Google Scholar 

  24. Alexander JL, Kalaaji AN, Shehan JM, Yokei BK, Pittelkow MR (2006) Plasmapheresis for refractory urticarial vasculi-tis in a patient with B-cell chronic lymphocytic leukaemia. J Drugs Dermatol 5(6):534–537

    PubMed  Google Scholar 

  25. Arin MJ, Hunzelmann N (2005) Anti-B- cell-directed immu-notherapy (rituximab) in the treatment of refractory pemphi-gus–an update. Eur J Dermatol 15(4):224–230

    PubMed  CAS  Google Scholar 

  26. Scheinfeld N (2006) Review of rituximab in cutaneous medicine. Dermatol Online J 12(1):3

    PubMed  Google Scholar 

  27. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U (2006) Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173(2):180–187

    Article  PubMed  CAS  Google Scholar 

  28. Noss EH, Hausner-Sypek DL, Weinblatt ME (2006) Rituximab as therapy for refractory polymyositis and der-matomyositis. J Rheumatol 33(5):1021–1026

    PubMed  Google Scholar 

  29. Dinh HV, McCormack C, Hall S, Prince HM (2007) Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases. J Am Acad Dermatol 56(1):148–153

    Article  PubMed  Google Scholar 

  30. Dorner T, Lipsky PE (2007) B-cell targeting: a novel approach to immune intervention today and tomorrow. Expert Opin Biol Ther 7(9):1287–1299

    Article  PubMed  Google Scholar 

  31. Tobin AM, Kirby B (2005) TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs 19(1):47–57

    Article  PubMed  CAS  Google Scholar 

  32. Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y, Braun J, Reed E, Gjertson D, Singh RR (2008) TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 126:13–30

    Article  PubMed  CAS  Google Scholar 

  33. Toussirot E, Wendling D (2004) The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Expert Opin Pharmacother 5(3):581–594

    Article  PubMed  CAS  Google Scholar 

  34. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352(4):351–361

    Article  Google Scholar 

  35. Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yazici H (2005) Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32(1):98–105

    PubMed  CAS  Google Scholar 

  36. Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H (2007) Anti-TNF therapy in the management of Behcet's disease– review and basis for recommendations. Rheumatology (Oxford) 46(5):736–741

    Article  CAS  Google Scholar 

  37. Mukhtyar C, Luqmani R (2005) Current state of tumour necrosis factor alpha blockade in Wegener's granulomatosis. Ann Rheum Dis 64 (suppl 4):iv31—iv36

    Article  PubMed  CAS  Google Scholar 

  38. Atzeni F, Sarzi-Puttini P, Capsoni F, Mecchia M, Marrazza MG, Carrabba M (2005) Successful treatment of resistant Behcet's disease with etanercept. Clin Exp Rheumatol 23(5):729

    PubMed  CAS  Google Scholar 

  39. Jarret SJ, Cunnane G, Conaghtan PG et al (2003) Anti-tumor necrosis factor alpha therapy induced vasculitis. Case series. J Rheumatol 30:2287–2291

    Google Scholar 

  40. Saint Marcoux B, De Bandt M; CRI (Club Rhumatismes et Inflammation) (2006) Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 73(6):710–713

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Cologne, Kerpener Straβe 62, Köln, 50937, Germany

    Nicolas Hunzelmann

Authors
  1. Nicolas Hunzelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolas Hunzelmann .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Köln Klinik und Poliklinik für Dermatologie und Venerologie, Kerpener Str. 62, Köln, 50924, Germany

    Thomas Krieg

  2. Dept. Dermatology, Columbia University Medical Center, 12th Floor, Herbert Irving Pavilion 161 Fort Washington Ave, New York, NY, 10032, USA

    David R. Bickers

  3. Dept. Dermatology & Cutaneous Sciences, Kyoto University Graduate School of Medicine, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Yoshiki Miyachi

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hunzelmann, N. (2010). Cutaneous Vasculitis. In: Krieg, T., Bickers, D.R., Miyachi, Y. (eds) Therapy of Skin Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78814-0_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78814-0_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78813-3

  • Online ISBN: 978-3-540-78814-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation